Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

Abstract

Palliative chemotherapy can be delivered to patients with recurrent HCC after liver transplantation with tolerable toxicity. However, the efficacy to date is not satisfactory. Therefore, more effective systemic chemotherapy is needed for this group of patients.